Literature DB >> 18985632

Does chemotherapy increase morbidity and mortality after pneumonectomy?

Stolz Alan1, Simonek Jan, Harustiak Tomas, Lischke Robert, Schutzner Jan, Pafko Pavel.   

Abstract

BACKGROUND: The impact of chemotherapy on postoperative complications after pneumonectomy remains unclear, and the procedure is often considered as potentially dangerous.
METHODS: This retrospective review of prospectively collected data included 269 patients operated from January 1, 1998 through December 31, 2007. Group 1 included patients those who received preoperative chemotherapy (PCT) and pneumonectomy (54 patients, 20%), and group 2 included patients who underwent pneumonectomy alone (215 patients, 80%).
RESULTS: Overall 30- and 90-day mortality rates were 5.9% and 8.9%, respectively. Postoperative mortality at 30 days was 5.6% in group 1 and 6% in group 2 (P = 0.16), and 11.1% for group 1 and 8.3% in group 2 at 90 days (P = 0.8). Incidence of postoperative respiratory failure was 3.7% in group 1 and 3.2% in group 2 (P = 0.62); incidence of empyema was 5.5% in group 1 and 2.8% in group 2 (P = 0.1). Incidence of bronchopleural fistula (BPF) was 3.7% in group 1 and 2.8% in group 2 (P = 0.55); risk of BPF was higher following right pneumonectomy (6.1%) versus left pneumonectomy (0%, P = 0.003).
CONCLUSIONS: PCT does not significantly increase postoperative morbidity and early mortality after pneumonectomy in our experience.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18985632     DOI: 10.1002/jso.21181

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  1 in total

1.  Survival after Pneumonectomy for Stage III Non-small Cell Lung Cancer.

Authors:  Sibu P Saha; Rohan J Kalathiya; Daniel L Davenport; Victor A Ferraris; Timothy W Mullett; Joseph B Zwischenberger
Journal:  Oman Med J       Date:  2014-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.